In-principle approval from BSE and NSE received for 16,21,000 convertible warrants
In-principle approval received from BSE and NSE for issue of 16,21,000 convertible warrants on preferential basis to the Promoter and Promoter Group.
- Convertible Warrants
- 16,21,000 convertible warrants on preferential basis to Promoter and Promoter Group
- Conversion Terms
- 16,21,000 equity shares of face value Rs. 5/- each
- Issue Price
- Rs. 566/- each
What was announced
The company informed BSE Limited and National Stock Exchange of India Limited that it has received in-principle approval for the issue of 16,21,000 convertible warrants on a preferential basis to the Promoter and Promoter Group.
Key terms as stated
- Warrants: 16,21,000
- Convertible into: 16,21,000 equity shares of face value Rs. 5/- each
- Issue price: Rs. 566/- each
- Allottees: Promoter and Promoter Group of the company
- Route: preferential basis in terms of Regulation 28(1)
What an in-principle approval is
In-principle approval is the exchanges' clearance for the securities being issued to be listed once the process is completed. The NSE letter sets out conditions the company must fulfil, including:
- Update the listing application at the earliest from the date of allotment
- Receipt of statutory and other approvals, and compliance with guidelines of statutory authorities including SEBI, RBI and MCA
- Compliance with all applicable guidelines, regulations and directions of the exchange or any statutory authorities as on the date of listing application
- Compliance with all conditions under SEBI (LODR) Regulations, 2015, Companies Act, 1956 / Companies Act, 2013 and other applicable laws
- Submission of documents as may be required by NSE and payment of applicable fees
Additional points in the NSE letter
- The company is advised to strengthen internal controls to monitor trades executed by the proposed allottees in the scrip before allotment of securities
- The company is advised to obtain an undertaking from the allottee(s) that they will not do intra-day trading in the scrip or any sale in the scrip till the allotment date
- The onus to verify this and ensure compliance, including with Regulation 167(6) of the SEBI ICDR Regulations, 2018, is solely on the issuer company
- Any non-compliance observed by the exchanges after the undertaking and verification may impact the listing of such shares
- The exchange reserves the right to withdraw the in-principle approval at a later stage if the information submitted is found incomplete, incorrect, misleading, false or in contravention of applicable rules and regulations
Point on the BSE letter
The in-principle approval letter received from BSE contains certain factual errors that require rectification. The company has stated that the corrected letter will be intimated to the exchanges separately upon its receipt.
What investors may note
- On conversion, the warrants would result in the issue of 16,21,000 equity shares at Rs. 566/- each to the Promoter and Promoter Group.
- The approval is in-principle and comes with conditions; the listing of the shares would follow those conditions being met.
Also from Krsnaa Diagnostics
In-principle approval received from BSE and NSE for 16,21,000 convertible warrants
8 Oct 2026
Kirtane & Pandit LLP Appointed Statutory Auditor for Five-Year Term
30 Sep 2026
Board approves sale of identified diagnostic equipment for up to ₹120 crore
28 Sep 2026
More numbers
- Convertible warrants for which in-principle approval received16,21,000
- Equity shares on conversion of the warrants16,21,000
- Face value per equity shareRs. 5/-
- Issue price per warrant / shareRs. 566/-
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.